Dosimetry of a D2/D3 Dopamine Receptor Antagonist That Can Be Used with PET or SPECT

P. David Mozley; James B. Stubbs; Hee-Joung Kim; Will McElgin; Sumalee Chumpradit; Mei-Ping Kung; Gemma Romaniello; Hank F. Kung

Research ArticleDosimetry

Dosimetry of a D2/D3 Dopamine Receptor Antagonist That Can Be Used with PET or SPECT

P. David Mozley, James B. Stubbs, Hee-Joung Kim, Will McElgin, Sumalee Chumpradit, Mei-Ping Kung, Gemma Romaniello and Hank F. Kung

Journal of Nuclear Medicine July 1995, 36 (7) 1322-1331;

P. David Mozley

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

James B. Stubbs

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hee-Joung Kim

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Will McElgin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sumalee Chumpradit

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mei-Ping Kung

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gemma Romaniello

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hank F. Kung

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 36, Issue 7

July 1, 1995

Table of Contents
Table of Contents (PDF)
Index by author
Advertising (PDF)
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Dosimetry of a D2/D3 Dopamine Receptor Antagonist That Can Be Used with PET or SPECT

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Dosimetry of a D2/D3 Dopamine Receptor Antagonist That Can Be Used with PET or SPECT

P. David Mozley, James B. Stubbs, Hee-Joung Kim, Will McElgin, Sumalee Chumpradit, Mei-Ping Kung, Gemma Romaniello, Hank F. Kung

Journal of Nuclear Medicine Jul 1995, 36 (7) 1322-1331;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Dosimetry of a D2/D3 Dopamine Receptor Antagonist That Can Be Used with PET or SPECT

P. David Mozley, James B. Stubbs, Hee-Joung Kim, Will McElgin, Sumalee Chumpradit, Mei-Ping Kung, Gemma Romaniello, Hank F. Kung

Journal of Nuclear Medicine Jul 1995, 36 (7) 1322-1331;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Clinical Characterization of [18F]T-008, a Cholesterol 24-Hydroxylase PET Ligand: Dosimetry, Kinetic Modeling, Variability, and Soticlestat Occupancy
Safety, Biodistribution, and Dosimetry of 123I-IMPY: A Novel Amyloid Plaque-Imaging Agent for the Diagnosis of Alzheimer's Disease

Google Scholar

Main menu

User menu

Search

Dosimetry of a D2/D3 Dopamine Receptor Antagonist That Can Be Used with PET or SPECT

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles